{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:01:57Z","timestamp":1784001717039,"version":"3.55.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.nec.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T07:34:03Z","timestamp":1385019243000},"page":"33-46","source":"Crossref","is-referenced-by-count":35,"title":["Sacral Neuromodulation for Refractory Overactive Bladder, Interstitial Cystitis, and Painful Bladder Syndrome"],"prefix":"10.1016","volume":"25","author":[{"given":"Aaron","family":"Laviana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest","family":"Jellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib1","first-page":"441","article-title":"Bilateral S3 stimulator in patients with interstitial cystitis","volume":"69","author":"Steinberg","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib2","first-page":"1369","article-title":"Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study","volume":"169","author":"Comiter","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00192-007-0466-x","article-title":"Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain","volume":"19","author":"Zabihi","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"10","key":"10.1016\/j.nec.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1464-410X.2010.09702.x","article-title":"An update on sacral neuromodulation: where do we stand with this in the management of lower urinary tract dysfunction in 2010?","volume":"106","author":"Bosch","year":"2010","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11934-012-0272-y","article-title":"The role of neuromodulation in patients with neurogenic overactive bladder","volume":"13","author":"Lay","year":"2012","journal-title":"Curr Urol Rep"},{"issue":"6 Suppl 1","key":"10.1016\/j.nec.2013.08.001_bib6","first-page":"32","article-title":"Interstitial cystitis: a chronic visceral pain syndrome","volume":"57","author":"Wesselmann","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"12","key":"10.1016\/j.nec.2013.08.001_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00192-010-1281-3","article-title":"Sacral neuromodulation stimulation for IC\/PBS, chronic pelvic pain, and sexual dysfunction","volume":"21","author":"Fariello","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib8","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/nau.20786","article-title":"Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systemic review","volume":"29","author":"Siddiqui","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1756287212445179","article-title":"Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem","volume":"4","author":"Banakhar","year":"2012","journal-title":"Ther Adv Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib10","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1007\/s00192-010-1273-3","article-title":"Mechanism of action of sacral neuromodulation","volume":"21","author":"Elkelini","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.nec.2013.08.001_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ucl.2004.09.004","article-title":"How sacral nerve stimulation neuromodulation works","volume":"32","author":"Leng","year":"2005","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib12","first-page":"2268","article-title":"Changes in brain activity following sacral neuromodulation for urinary retention","volume":"174","author":"Dasgupta","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/nau.21240","article-title":"Brain activity underlying impaired continence control in older women with overactive bladder","volume":"31","author":"Tadic","year":"2012","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.eururo.2008.01.076","article-title":"Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety","volume":"54","author":"Spinelli","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/nau.20345","article-title":"Sacral nerve stimulation for voiding dysfunction: one institution\u2019s 11-year experience","volume":"26","author":"Sutherland","year":"2007","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/0970-1591.70576","article-title":"Sacral neuromodulation: therapy evolution","volume":"26","author":"Thompson","year":"2010","journal-title":"Indian J Urol"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib17","first-page":"358","article-title":"Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant","volume":"49","author":"Janknegt","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11934-010-0128-2","article-title":"Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation","volume":"11","author":"Baxter","year":"2010","journal-title":"Curr Urol Rep"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2004.11.005","article-title":"Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?","volume":"47","author":"Kessler","year":"2005","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib20","first-page":"2046","article-title":"Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction","volume":"168","author":"Scheepens","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.nec.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/nau.20577","article-title":"Unilateral versus bilateral stage 1 neuromodulator lead placement for the treatment of refractory voiding dysfunction","volume":"27","author":"Pham","year":"2008","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib22","first-page":"976","article-title":"The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy","volume":"185","author":"Marcelissen","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.nec.2013.08.001_bib23","series-title":"Female urology","first-page":"266","article-title":"Sacral neuromodulation for the treatment of overactive bladder (OAB)","author":"Siegel","year":"2008"},{"issue":"7","key":"10.1016\/j.nec.2013.08.001_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/nau.20174","article-title":"Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial","volume":"24","author":"Peters","year":"2005","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 1","key":"10.1016\/j.nec.2013.08.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-410X.2005.05648.x","article-title":"Urgency: the key to defining overactive bladder","volume":"96","author":"Abrams","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.nec.2013.08.001_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3410\/M4-20","article-title":"The CNS and bladder dysfunction","volume":"4","author":"Tadic","year":"2012","journal-title":"F1000 Med Rep"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","article-title":"The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey","volume":"7","author":"Coyne","year":"2004","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.nec.2013.08.001_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","article-title":"Health-related quality of life among adults with symptoms of overactive bladder: results from a community-based survey","volume":"57","author":"Liberman","year":"2001","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"issue":"20","key":"10.1016\/j.nec.2013.08.001_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","article-title":"The economic impact of overactive bladder syndrome in six Western countries","volume":"103","author":"Irwin","year":"2009","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib32","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.nec.2013.08.001_bib33","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.nec.2013.08.001_bib34","first-page":"S580","article-title":"Overactive bladder significantly affects quality of life","volume":"6","author":"Abrams","year":"2000","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib35","first-page":"34","article-title":"Burden of illness associated with lower urinary tract symptoms including overactive bladder\/urinary incontinence","volume":"74","author":"Kannan","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.nec.2013.08.001_bib36","first-page":"S574","article-title":"Comorbidities associated with overactive bladder","volume":"6","author":"Brown","year":"2000","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1592\/phco.25.4.511.61033","article-title":"Costs associated with the management of overactive bladder and related comorbidities","volume":"25","author":"Darkow","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib38","first-page":"1077","article-title":"Overactive bladder medication adherence when medication is free to patients","volume":"183","author":"Sears","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"5773","key":"10.1016\/j.nec.2013.08.001_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib41","first-page":"1849","article-title":"Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety","volume":"163","author":"Hassouna","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000020134","article-title":"Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial","volume":"37","author":"Weil","year":"2000","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib43","first-page":"352","article-title":"Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group","volume":"162","author":"Schmidt","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.nec.2013.08.001_bib44","first-page":"835","article-title":"Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systemic review","volume":"175","author":"Brazzelli","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib45","first-page":"2029","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"van Kerrebroeck","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"6 Suppl 1","key":"10.1016\/j.nec.2013.08.001_bib46","first-page":"87","article-title":"Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention","volume":"56","author":"Sigel","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20330","article-title":"In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction","volume":"26","author":"Foster","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.nec.2013.08.001_bib48","author":"Comiter","year":"2013","journal-title":"AUA"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00192-011-1553-6","article-title":"Improvement of bowel dysfunction with sacral neuromodulation for refractory urge urinary incontinence","volume":"23","author":"Gill","year":"2012","journal-title":"Int Urogynecol J"},{"issue":"7","key":"10.1016\/j.nec.2013.08.001_bib50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/codi.12181","article-title":"Does sacral nerve stimulation improve global pelvic function in women?","volume":"15","author":"Jadav","year":"2013","journal-title":"Colorectal Dis"},{"issue":"12","key":"10.1016\/j.nec.2013.08.001_bib51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00384-009-0745-8","article-title":"Sacral\u00a0neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up","volume":"24","author":"El-Gazzaz","year":"2009","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/SPV.0b013e3181d67c24","article-title":"Sacral neuromodulation outcomes in patients with urge urinary incontinence and concomitant urge fecal incontinence","volume":"16","author":"Kim","year":"2010","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/nau.20975","article-title":"Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation","volume":"30","author":"Killinger","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000336911","article-title":"Sexual response in patients in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence","volume":"88","author":"van Voskuilen","year":"2012","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2012.03.005","article-title":"OnabotulinumtoxinA improves health-related quality of life in patients with urinary retention due to idiopathic overactive bladder: a 36-week, double-blinded, placebo-controlled, randomized, dose-ranging trial","volume":"62","author":"Fowler","year":"2012","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib56","first-page":"2258","article-title":"Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systemic review of the literature","volume":"183","author":"Anger","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib57","first-page":"2186","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib59","first-page":"2416","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.nec.2013.08.001_bib60","unstructured":"Meikle S, Amundsen C, Richter H, et\u00a0al. Refractory overactive bladder: sacral neuromodulation v. BoTulinum Toxin Assessment (ROSETTA) Trial. NIH. Available at: Clinicaltrialsfeeds.org."},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1464-410X.2006.06508.x","article-title":"Medium-term experience of sacral neuromodulation by tined lead implantation","volume":"99","author":"van Voskuilen","year":"2007","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.eururo.2005.11.009","article-title":"Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study","volume":"49","author":"van Voskuilen","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00345-005-0502-8","article-title":"New tined lead electrode in sacral neuromodulation: experience from a multicenter European study","volume":"23","author":"Spinelli","year":"2005","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib64","first-page":"1069","article-title":"Sacral neuromodulation: cost considerations and clinical benefits","volume":"70","author":"Aboseif","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ucl.2004.09.001","article-title":"Complications and troubleshooting of sacral neuromodulation therapy","volume":"32","author":"Hijaz","year":"2005","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib66","first-page":"1073","article-title":"Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation","volume":"69","author":"Guralnick","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"Suppl 4","key":"10.1016\/j.nec.2013.08.001_bib67","first-page":"73","article-title":"Rational approaches to the treatment of patients with interstitial cystitis","volume":"69","author":"Moldwin","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"van de Merwe","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/nau.20687","article-title":"Status of international consensus on interstitial cystitis\/bladder pain syndrome\/painful bladder syndrome: 2008 snapshot","volume":"28","author":"Hanno","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.nec.2013.08.001_bib71","unstructured":"Berry S, Bogart L, Soto M, et\u00a0al. Presented at the American Urological Association Annual Meeting. Chicago, April 25\u201329, 2009."},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ucl.2012.06.007","article-title":"Interstitial cystitis\/bladder pain syndrome: management of the pain disorder: a urogynecology perspective","volume":"39","author":"Butrick","year":"2012","journal-title":"Urol Clin North Am"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib73","first-page":"508","article-title":"Comparison of an interstitial cystitis\/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study","volume":"187","author":"Konkle","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00003081-200203000-00024","article-title":"Gynecologic manifestations of interstitial cystitis","volume":"45","author":"Myers","year":"2002","journal-title":"Clin Obstet Gynecol"},{"issue":"Suppl 4","key":"10.1016\/j.nec.2013.08.001_bib75","first-page":"9","article-title":"The role of the urinary epithelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis","volume":"69","author":"Parsons","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"Suppl 4","key":"10.1016\/j.nec.2013.08.001_bib76","first-page":"34","article-title":"The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis","volume":"69","author":"Sant","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib77","first-page":"720","article-title":"Interstitial cystitis\/painful bladder syndrome as a cause of sexual pain in women: a diagnosis to consider","volume":"4","author":"Whitmore","year":"2007","journal-title":"J\u00a0Sex Med"},{"issue":"Suppl 4","key":"10.1016\/j.nec.2013.08.001_bib78","first-page":"24","article-title":"Neural upregulation in interstitial cystitis","volume":"69","author":"Nazif","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00192-003-1070-3","article-title":"Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique","volume":"14","author":"Peters","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00192-003-1080-1","article-title":"Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial","volume":"14","author":"Whitmore","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib81","first-page":"884","article-title":"Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis","volume":"165","author":"Maher","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1464-410X.2003.04745.x","article-title":"Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis","volume":"93","author":"Peters","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.nec.2013.08.001_bib83","unstructured":"Rackley R, Vasavada S, Daneshagani F, et\u00a0al. Neuromodulation for interstitial cystitis 2005. Clev\u00a0Clin Glickman Urol Inst. Available at: http:\/\/my.clevelandclinic.org\/Documents\/Urology\/AUA%20Abstracts%202005.pdf."},{"issue":"4","key":"10.1016\/j.nec.2013.08.001_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00192-010-1235-9","article-title":"Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation","volume":"22","author":"Marinkovic","year":"2011","journal-title":"Int Urogynecol J"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib85","first-page":"173","article-title":"Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures","volume":"183","author":"Powell","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.nec.2013.08.001_bib86","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1464-410X.2010.09697.x","article-title":"The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre","volume":"107","author":"Gajewski","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib87","first-page":"1742","article-title":"Sacral nerve stimulation in patients with chronic intractable pelvic pain","volume":"166","author":"Siegel","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.nec.2013.08.001_bib88","first-page":"16","article-title":"Prevalence of pelvic floor dysfunction in patients with interstitial cystitis","volume":"70","author":"Peters","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.nec.2013.08.001_bib89","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SPV.0b013e3181907870","article-title":"Pelvic floor muscle dysfunction: a review","volume":"14","author":"Finamore","year":"2008","journal-title":"J\u00a0Pelvic Med Surg"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib90","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1464-410X.1997.00145.x","article-title":"The urodynamic evaluation of neuromodulation in patients with voiding dysfunction","volume":"79","author":"Everaert","year":"1997","journal-title":"Br J Urol"},{"issue":"5","key":"10.1016\/j.nec.2013.08.001_bib91","first-page":"643","article-title":"Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis","volume":"55","author":"Chai","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.nec.2013.08.001_bib92","first-page":"387","article-title":"Sacral neuromodulation as a treatment for chronic pelvic pain","volume":"186","author":"Marcelissen","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.nec.2013.08.001_bib93","unstructured":"Sacral Nerve Stimulation. 2012. Available at:\u00a0http:\/\/professional.medtronic.com\/therapies\/sacral-nerve-stimulation-interstim-therapy\/index.htm."},{"issue":"3","key":"10.1016\/j.nec.2013.08.001_bib94","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/nau.22294","article-title":"Battery explantation after sacral neuromodulation in the Medicare population","volume":"32","author":"Cameron","year":"2012","journal-title":"Neurourol Urodyn"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368013000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368013000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:00:48Z","timestamp":1597050048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368013000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1042368013000776"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2013.08.001","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}